ArticleAnatolian journal of cardiology2024

The Effect of Empagliflozin on Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Pathway in Patients with Type 2 Cardiorenal Syndrome.

Pei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.